Survey of effect of curcumin in coronary patients

The survey of oral intake effect of nano micelles curcumin on lipid profile ? inflammatory markers and stress oxidative factors in patients undergoing the coronary elective angioplasty; a placebo-controlled randomized clinical trial double-blind.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141025019669N6

Enrollment

Registered

2017-12-17

Start date

2017-12-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease. Cardiovascular disease

Interventions

Intervention 1: First intervention group: nanomicell curcumin, daily 80 mg. Intervention 2: Second intervention group: Curcumin, daily 80 mg. Intervention 3: Control group: Plasebo.

Treatment - Drugs

First intervention group: nanomicell curcumin, daily 80 mg

Second intervention group: Curcumin, daily 80 mg

Control group: Plasebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients undergoing the coronary elective angioplasty.

Exclusion criteria

Exclusion criteria: Patients with coronary problems in last month Patients with liver, gastrointestinal disorders and inflammatory diseases

Design outcomes

Primary

Measure	Time frame
Lipid profile. Timepoint: Before the intervention and after the intervention. Method of measurement: Eliza.;Inflammatory factors. Timepoint: Before the intervention and after the intervention. Method of measurement: Eliza.	—

Secondary

Measure	Time frame
Antioxidant indices. Timepoint: Before intervention and after intervention. Method of measurement: Eliza.;Malondialdehyde concentration. Timepoint: Before intervention and after intervention. Method of measurement: Eliza.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Bizhan Helli

Ahvaz University of Medical Sciences

bizhanhelli@yahoo.com+98 61 1373 8254

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026